Lung cancer wonder drug hailed as study shows ‘off the chart’ survival benefit
A lung cancer wonder drug has been shown to dramatically extend survival for patients with an incurable form of the disease. Experts said “unprecedented” results from a trial of the daily pill, lorlatinib, were among the best ever recorded for advanced lung cancer treatments. After five years, 60 percent of patients taking the drug had … Read more
